Pavlinac Patricia B, Tickell Kirkby D, Walson Judd L
University of Washington, Global Health, 325 Ninth Avenue, Box 359931, Seattle, WA 98104, USA.
Expert Rev Anti Infect Ther. 2015 Jan;13(1):5-8. doi: 10.1586/14787210.2015.981157. Epub 2014 Nov 11.
Globally, diarrhea is the second leading cause of death in children less than 5 years of age. HIV-infected and HIV-exposed uninfected (HEU) children are at high risk of dying from diarrhea and may be more susceptible to the highest risk enteric pathogens. This increased risk associated with HIV infection and HIV exposure is likely multifactorial. Factors such as immunosuppression, proximity to individuals more likely to be shedding pathogens, and exposure to antimicrobial prophylaxis may alter the risk profile in these children. Current international guidelines do not differentiate management strategies on the basis of whether children are infected or affected by HIV, despite likely differences in etiologies and consequences. Reducing diarrhea mortality in high HIV prevalence settings will require strengthening of HIV testing and treatment programs; improvements in water, sanitation and hygiene interventions targeted at HIV-affected households; and reconsideration of the use of empiric antimicrobial treatment of pathogens known to infect HIV-infected and HEU children disproportionately.
在全球范围内,腹泻是5岁以下儿童的第二大死因。感染艾滋病毒的儿童以及暴露于艾滋病毒但未受感染的儿童(HEU)死于腹泻的风险很高,并且可能更容易感染风险最高的肠道病原体。与艾滋病毒感染和暴露相关的这种风险增加可能是多因素的。免疫抑制、接近更可能排出病原体的个体以及接触抗菌预防措施等因素可能会改变这些儿童的风险状况。尽管病因和后果可能存在差异,但目前的国际指南并未根据儿童是否感染艾滋病毒或受其影响来区分管理策略。在艾滋病毒高流行地区降低腹泻死亡率将需要加强艾滋病毒检测和治疗项目;改善针对受艾滋病毒影响家庭的水、环境卫生和个人卫生干预措施;并重新考虑对已知不成比例地感染艾滋病毒感染儿童和HEU儿童的病原体进行经验性抗菌治疗的使用情况。